Abstract：Objective: To study the short-term clinical efficacy and safety of 1 470 nm-laser enucleation of the prostate for benign prostatic hyperplasia. Methods: The clinical data of 28 cases undergoing enucleation of prostate with domestic 1 470 nm-laser from December 2015 to March 2016 were briefly summarized. Results: The 1 470 nm-laser enucleation of the prostate was successfully performed on 28 cases, with less blood loss and no blood transfusion. The average operation time was (94.0±19.7) min. There was no significant difference in instant concentrations before and after operation (P>0.05). The postoperative bladder washing time was (1.6±0.5) days, indwelling catheter time was (4.1±1.0) days, and the length of hospital stay was (6.0±1.5) days. After a 3-month follow-up, International Prostatic Symptom score (IPSS), quality of life (QOL) score, maximum flow rates (Qmax), and postvoid residual volume (PVR) were significantly improved, and the difference was statistically significant (P<0.01). Transient urinary incontinence recovered within one month after pelvic muscle exercises in 4 cases. There were no patients with urethral stricture or the need for a further surgery. Conclusions: Treatment of benign prostatic hyperplasia with 1 470 nm-laser enucleation of the prostate is a safe and effective surgical method, with few complications and speedy recovery.
[1]Gordon NS, Hadlow G, Knight E, et al. Transurethral resection of the prostate:still the gold standard. Aust N Z J Surg,1997,67(6):354-357. [2]那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南(2014版).北京:人民卫生出版社,2014:259-261. [3]Fu WJ, Hong BF, Yang Y, et al. Vaporesection for managing benign prostatic hyperplasia using a 2-micron continuous wave laser:a prospective trial with 1-year follow-up. BJU Int, 2009,103(3):352-356. [4]Fayad AS, Sheik HMG, Zakaria T, et al. Holmium laser enucleation versus bipolar resection of the prostate: a prospective randomized study. Which to choose? J Endourol, 2011,25(8):1347-1352. [5]Bouvhier-Hayes DM, Van Appledorn S, Bugeja P, et al. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int, 2010,105(7):964-969. [6]Seitz M, Sroka R, Gratzke C, et al. The diode laser: a novel side-firing approach for laser vaporisation of the human prostate-immediate efficacy and 1-year follow-up. Eur Urol, 2007,52(6):1717-1722. [7]刘志峰,赵永伟,刘义东,等.1470nm 半导体激光汽化术治疗前列腺增生(附156例报告).微创泌尿外科杂志,2015,4(1):20-22. [8]陈忠,马俊,杨竣,等.1470nm 激光直出光纤TURP式前列腺汽化剜除术治疗良性前列腺增生初步报告.现代泌尿生殖肿瘤杂志,2015,7(1):5-8. [9]Seitz M, Ruszat R, Bayer T, et al. Ex vivo and in vivo investigation of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Laser Med Sci, 2009,24(3):419-424.
